It has been reported that the CHD5 promoter was strongly methylated in the –780 to –450 region (Figure S2) in neuroblastoma cell lines with 1p36 deletions, but not cell lines with two copies of the CHD5 gene [36]. The gene discussed is CHD5; the disease is neuroblastoma.